Lack of Association Between Extracranial Carotid and Vertebral Artery Disease and Stroke After Transcatheter Aortic Valve Replacement Chetan P. Huded, MD, MSc, Quentin R. Youmans, MD, Jyothy J. Puthumana, MD, Ranya N. Sweis, MD, MSc, Mark J. Ricciardi, MD, Sukit Chris Malaisrie, MD, Charles J. Davidson, MD, James D. Flaherty, MD, MSc Canadian Journal of Cardiology Volume 32, Issue 12, Pages 1419-1424 (December 2016) DOI: 10.1016/j.cjca.2016.03.010 Copyright © 2016 Canadian Cardiovascular Society Terms and Conditions
Figure 1 Thirty-day stroke and death after transcatheter aortic valve replacement (TAVR) by carotid and vertebral artery disease (CVD) status. Paradoxically, there was a lower rate of stroke in the CVD group compared with the non-CVD group. There was no impact of CVD status on 30-day mortality. Canadian Journal of Cardiology 2016 32, 1419-1424DOI: (10.1016/j.cjca.2016.03.010) Copyright © 2016 Canadian Cardiovascular Society Terms and Conditions
Figure 2 Survival after transcatheter aortic valve replacement (TAVR) by carotid and vertebral artery disease (CVD) status. There was no difference in overall survival between the CVD and non-CVD groups by log-rank test. Median follow-up was 0.61 years, and maximum follow-up was 6.19 years in the entire cohort. Canadian Journal of Cardiology 2016 32, 1419-1424DOI: (10.1016/j.cjca.2016.03.010) Copyright © 2016 Canadian Cardiovascular Society Terms and Conditions